TGF-β–treated SSc fibroblasts demonstrated a significant reduction in TGF-β–induced α-SMA expression (P = 0.03) and showed a trend toward reduced Col1a1 expression, whereas no reduction in fibrotic gene expression was observed in healthy control fibroblasts (Supplemental Figure 4). Here, COL1A1 is linked to systemic sclerosis.